Tourniquet Systems Market Analysis

Tourniquet Systems Market Analysis

Based on component, the tourniquet systems market is segmented as tourniquet instruments and tourniquet cuffs. The tourniquet cuffs is further segmented as pneumatic and non-pneumatic systems. The pneumatic tourniquet cuffs is further bifurcated into disposable and reusable. The tourniquet cuffs held a dominant market share in 2022 accounting for more than 68% of the total market share. This is owing to several benefits offered by tourniquet cuffs during a variety of upper as well as lower limb surgeries.
 

This equipment inherit the capability to control haemorrhage and minimize blood loss, thereby improving visualization and efficiency during surgery. With improved visualization and controlled bleeding, surgeons can perform surgeries more efficiently and effectively. Therefore, owing to aforementioned factors and other advantages including less tissue trauma, precise pressure control, etc. is expected to augment the tourniquet systems industry landscape.
 

Based on application, the tourniquet systems market is segmented as upper-limb and lower-limb. The lower-limb accounted for major market share in 2022 and is expected to grow at 7.6% CAGR by 2032. Increasing prevalence of orthopedic surgeries is projected to augment the product demand. For instance, according to an article published by NCBI, in 2021, around 2.6 million people undergo knee replacement surgery across the globe. This incidence rate is anticipated to increase due to ageing population, degenerative bone disorder and rising trauma cases among others. Enhanced surgical precision, reduced blood loss, improved post-operative pain control are some of the major factors influencing the uptake of advance tourniquet systems in several healthcare facilities globally.
 

Based on end-use, the tourniquet systems market is segmented as hospitals, ambulatory surgical centers and others. The hospital segment is projected to grow at 7.9% CAGR from 2023-2032. This is owing to the availability of advanced tourniquet systems for the diagnosis and treatment of varied chronic ailments. Enhanced operability and accessibility to comprehensive range of treatments incorporating tourniquet systems is expected to drive the market revenue. Increasing admissions with orthopedic diseases, trauma and accidents and ageing related disorders are increasing the instances of hospitalizations with a robust healthcare system is expected to boost the industry size.
 

The U.S. tourniquet systems market is predicted to reach around USD 358 million by 2032. This is attributable to numerous variables including the presence of key market players, an increase in the number of chronic diseases, and rising awareness regarding the benefits of tourniquet systems for diagnosis and treatment of joint ailments among others.
 

For instance, according to the CDC report, in 2021, around 32 million people in the U.S. were suffering from osteoarthritis and is expected to increase in the near future. Tourniquet systems are one of the important devices used in diagnosis and treatment of these disorders. The higher incidence of these diseases has resulted in the surged number of minimally invasive procedures that is anticipated to fuel the product adoption rate.